Statins sygnificantly reduce cardiovascular mortality and morbidity. However, for statin myopathy can not be administered to sensitive individuals.
By monitoring of 28 patients. Patients received a reduced form of coenzyme Q10 at a dose of 30 mg twice a period of six months.
Muscle pain decreased after six moinths of use of the KQ10 53,88% and muscle weakness by 44%. Serum conxcentrations KQ10 increased by 194%.